3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Pancreatic Neoplasms
50
Colorectal Neoplasms
39
Stomach Neoplasms
27
Carcinoma, Hepatocellular
26
Ovarian Neoplasms
25
Melanoma
21
Breast Neoplasms
20
Carcinoma, Non-Small-Cell Lung
19
Neoplasms
15
Neoplasm Metastasis
15
Colonic Neoplasms
14
Esophageal Neoplasms
13
Uterine Cervical Neoplasms
11
Sarcoma
10
Liver Neoplasms
10
Carcinoma, Renal Cell
10
Lung Neoplasms
9
Anus Neoplasms
9
Rectal Neoplasms
8
Head and Neck Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Osteosarcoma
7
Triple Negative Breast Neoplasms
6
Mesothelioma
6
Hepatoblastoma
6
Gastrointestinal Neoplasms
6
Carcinoma
6
Adenocarcinoma
6
Vaginal Neoplasms
5
Small Cell Lung Carcinoma
5
Interventions
Nivolumab
3
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
trifluridine tipiracil drug combination
1
entinostat
1
X-Rays
1
Phantoms, Imaging
1
Oxaliplatin
1
Leucovorin
1
Ipilimumab
1
Imatinib Mesylate
1
Fluorouracil
1
Fentanyl
1
E-7386
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Bone Density
1
Blood Specimen Collection
1
Bevacizumab
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Desmoid Tumors
×
Cyclophosphamide
×
Gastrointestinal
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled